Obesity Clinical Trials in Philadelphia

Showing 61-80 of 202 trials

Using Artificial Intelligence to Optimize Delivery of Weight Loss Treatment

NCT05231824

Project ReLearn is testing the efficacy and cost-effectiveness of an Artificial Intelligence system for optimizing weight loss coaching. Participants are randomized to a 1-year weekly gold standard behavioral weight loss remote (video) group treatment or the AI-optimized treatment, which is made up of a combination of remote group treatment, short video call and automated message. In the AI-optimized condition, the system monitors outcomes (via wireless scale, mobile phone app, and wristworn tracker) and, each week, assigns each participant the treatments they have responding to the best, within certain time constraints.

ObesityWeight Loss

Drexel University336 participantsStarted Mar 2022

Philadelphia, Pennsylvania, United States

COMPLETEDPhase 2< 1 mile

DAYBREAK: A Study of Setmelanotide in Participants With Specific Gene Variants in the Melanocortin-4 Receptor (MC4R) Pathway

NCT04963231

The purpose of this study was to evaluate the safety and efficacy of once daily subcutaneous (SC) administration of setmelanotide in participants with obesity and specific gene variants in the MC4R pathway.

Genetic Obesity

Rhythm Pharmaceuticals, Inc.164 participantsStarted Nov 2021

Scottsdale, Arizona, United States • Suwanee, Georgia, United States • Worcester, Massachusetts, United States +33 more locations

Using Artificial Intelligence to Optimize Delivery of Weight Loss Treatment

DAYBREAK: A Study of Setmelanotide in Participants With Specific Gene Variants in the Melanocortin-4 Receptor (MC4R) Pathway

Obesity Trials in Other Cities

A Study to Investigate Why Overweight People Regain Weight After Losing Weight in a Behavioral Weight Loss Program

Long Term Extension Trial of Setmelanotide

Improving Participation in Universal School Meals (USM)

Low GI Diet in Children and Adolescents With ALL

Improving Sleep, Decision-Making, and Eating in Adolescents with Obesity

Muscle OXPHOS and Nutrient Homeostasis

Project Health: Enhancing Effectiveness of a Dissonance-Based Obesity Prevention Program

A Study of Tirzepatide (LY3298176) in Participants With Heart Failure With Preserved Ejection Fraction (HFpEF) and Obesity: The SUMMIT Trial

Trial to Learn About the Study Medicine (PF-07081532) and Rybelsus in People With Type 2 Diabetes and Separately PF-07081532 in People With Obesity

GI Tract Biomarkers in Infants With Different Diets

A Study of Retatrutide (LY3437943) in Participants With Obesity and Cardiovascular Disease

Spatz3 Adjustable Balloon System® (Spatz3) Post Approval Study

Study of Once-Daily Oral RGT001-075 Compared With Placebo in Adults With Obesity or Are Overweight With Weight-Related Health Conditions

Pediatric Obesity Weight Evaluation Registry (POWER) Study

Efficacy and Safety of GZR18 Every 2 Weeks Versus Tirzepatide and Placebo in Obese or Overweight Participants

International Weight Control Registry

Cardiovascular Risk Screening and Risk Reduction in Women Vets

A Dose-Range Study of Aleniglipron (GSBR-1290) in Participants Living With Obesity or Overweight With at Least One Weight-related Comorbidity

Other Conditions in Philadelphia